Metraipolis › archive › dc_bd39528346be
Immunotherapy 3.0: Breakthroughs Steering the Next Generation of Cancer Control — Europe PMC PMID:42267720
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42267720
- DOI
- 10.1002/cnr2.70602
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-31T23:49:06.299Z
- SHA-256 of the archived text
abddeae750b92bfc8c1a9b9cee05d966064cd0724a199c742941dfadff554fb3- Stable URL of this page
https://metraipolis.com/documento/dc_bd39528346be
How to cite
Immunotherapy 3.0: Breakthroughs Steering the Next Generation of Cancer Control — Europe PMC PMID:42267720 — Europe PMC (en), https://europepmc.org/article/MED/42267720 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bd39528346be (Metraipolis archive dc_bd39528346be, sha256 abddeae750b92bfc8c1a9b9cee05d966064cd0724a199c742941dfadff554fb3)
BibTeX
@misc{dcbd39528346be,
title = {Immunotherapy 3.0: Breakthroughs Steering the Next Generation of Cancer Control — Europe PMC PMID:42267720},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42267720},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bd39528346be; sha256 abddeae750b92bfc8c1a9b9cee05d966064cd0724a199c742941dfadff554fb3},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42267720. Agents can read the archived copy with the MCP tool read_document.